Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

[1] Beal MF(2003)Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann NY Acad Sci 991 120-31

[2] McGeer PL(1988)Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285-91

[3] Itagaki S(2004)Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation Cell Tissue Res 318 149-61

[4] Boyes BE(2003)Distribution of major histocompatibility class II-positive microglia and cytokine profile of Parkinson's disease brains Acta Neuropathol (Berl) 106 518-26

[5] McGeer EG(1988)Rate of cell death in parkinsonism indicates active neuropathological process Ann Neurol 24 574-6

[6] Teismann P(1994)Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients Neurosci Lett 180 147-50

[7] Schulz JB(2000)Changes in cytokines and neurotrophins in Parkinson's disease J Neural Transm Suppl 60 277-90

[8] Imamura K(1999)The inflammatory reaction following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication in mouse Exp Neurol 156 50-61

[9] Hishikawa N(2003)Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease Eur J Neurosci 18 2731-42

[10] Sawada M(2003)Non-steroidal anti-inflammatory drugs and the risk of Parkinson's disease Arch Neurol 60 1059-64

[1] Beal MF(2003)Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann NY Acad Sci 991 120-31

[2] McGeer PL(1988)Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285-91

[3] Itagaki S(2004)Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation Cell Tissue Res 318 149-61

[4] Boyes BE(2003)Distribution of major histocompatibility class II-positive microglia and cytokine profile of Parkinson's disease brains Acta Neuropathol (Berl) 106 518-26

[5] McGeer EG(1988)Rate of cell death in parkinsonism indicates active neuropathological process Ann Neurol 24 574-6

[6] Teismann P(1994)Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients Neurosci Lett 180 147-50

[7] Schulz JB(2000)Changes in cytokines and neurotrophins in Parkinson's disease J Neural Transm Suppl 60 277-90

[8] Imamura K(1999)The inflammatory reaction following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication in mouse Exp Neurol 156 50-61

[9] Hishikawa N(2003)Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease Eur J Neurosci 18 2731-42

[10] Sawada M(2003)Non-steroidal anti-inflammatory drugs and the risk of Parkinson's disease Arch Neurol 60 1059-64